Navigation Links
Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
Date:1/12/2009

    Major milestone achieved bringing Enerkem one step closer to becoming the
    first producer of biofuels and biochemicals to commercially use waste
    feedstock

MONTREAL, Jan. 12 /PRNewswire/ - Enerkem Inc., a leading advanced biofuels and biochemicals technology company, announced today that its first commercial-scale plant located in Westbury, Quebec, is entering the start-up phase with the production of its clean conditioned synthesis gas.

Construction on the plant began in October 2007 and the facility was mechanically complete in December 2008. The conditioned synthesis gas ("syngas") island has been finalized and is in an advanced commissioning stage in preparation for its upcoming start-up. The premium syngas island serves as the chemical production platform, from which the methanol and ethanol production modules will be added progressively over the next months. Once these gas-to-liquid modules are bolted to the syngas island, Enerkem will become the first producer of liquid fuels and green chemicals to commercially use renewable, non-food, negative-cost feedstock.

"The conditioned synthesis gas island is the core of our technology platform as it is where we produce a clean tailored syngas that serves as a chemical source for the production of advanced biofuels and biochemicals," said Mr. Vincent Chornet, President and Chief Executive Officer of Enerkem. "We have followed a rigorous path to commercialization since the beginning of our pilot plant back in 2003 and we intend to apply the same disciplined approach at Westbury. The first step is our premium syngas which leads to our goal of becoming a world leader in the production of second-generation transportation fuels and green chemicals."

The company's Westbury plant will be the world's first ethanol plant to use negative-cost and unconventional materials - treated wood from used electricity poles. It is operated by a team of 13 people and will, at term, produce 5 million litres (1.3 million gallons) of second-generation ethanol annually. The Enerkem thermo-chemical process uses one tonne of waste to produce 360 litres (95 gallons) of ethanol: enough fuel for a car to travel 2,500 km (1,550 miles), the distance from Winnipeg to Montreal, or Los Angeles to Houston.

Enerkem's renewable fuels represent a new technology path towards environmentally friendly energy, contributing to the reduction of greenhouse gas emissions by using materials that would otherwise produce methane when landfilled and by producing a renewable fuel for cars, buses and trucks. Unlike first-generation biofuels, or agrofuels, which are produced from sugar-rich crops such as corn and sugar cane, Enerkem's second-generation biofuels are produced from biomass and waste materials.

About Enerkem

Enerkem (www.enerkem.com) is a leader in the development and production of advanced biofuels and green chemicals. The company is headquartered in Montreal, Quebec, and has engineering offices in Sherbrooke, Quebec. Enerkem's gasification, sequential gas conditioning and catalysis technology converts sorted municipal solid waste, as well as forest and agricultural residues into second generation transportation fuels and green chemicals. The company has a pilot plant in operation since 2003 in Sherbrooke, Quebec. Its first commercial-scale ethanol plant based in Westbury, Quebec, is entering start-up phase and the company will soon begin the construction of a third plant in Edmonton, Alberta, that will transform sorted household waste into ethanol for cars, buses and trucks. Enerkem is a private company financed by leading US venture capital firms Rho Ventures and Braemar Energy Ventures, the Canadian investment fund BDR Capital and the Company's management.

NOTE TO EDITOR:

A video of the plant is available via this link: http://www.enerkem.com/index.php?module=CMS&id=11&newlang=eng


'/>"/>
SOURCE ENERKEM INC.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Enerkem Expands Executive Management Team
2. GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality
3. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
4. SemBioSys announces senior management changes
5. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
6. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
7. Victhom Announces Launch of Enhanced Company Website
8. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
9. Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
10. Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
11. NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. Ltd. ... KRW (US $18.9M) Series A financing. This financing round ... Tech Venture and SNU Bio Angel. This new funding ... billion KRW (US $27.7M) since its founding in 2015. ... bolster the development and commercialization of its immuno-oncology programs, ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selectorâ„¢ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
Breaking Biology Technology:
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):